ProQR Therapeutics N.V. | Key People and Executives
James Samuel Shannon
Member-Supervisory Board
Domenico Valerio
Chairman-Supervisory Board
Paul Baart
Member-Supervisory Board
Alison Francis Lawton
Member-Supervisory Board
Antoine Papiernik
Member-Supervisory Board
Daniel Anton de Boer
Chief Executive Officer
Smital Shah
Chief Financial Officer
David M. Rodman
Executive Vice President-Research & Development
Gerard J. Platenburg
Chief Innovation Officer
James Samuel Shannon
Member-Supervisory Board
Bonnie Ortega
Director-Investor Relations
Sariette Witte
Director-Corporate Communications
Robert Cornelisse
Chief People & Organization Officer
René Beukema
General Counsel
Domenico Valerio
Chairman-Supervisory Board
Paul Baart
Member-Supervisory Board
Alison Francis Lawton
Member-Supervisory Board
Antoine Papiernik
Member-Supervisory Board
| Address |
Zernikedreef 9
Leiden Zuid-Holland 2333 CK
Netherlands
|
|
Employees
|
- |
| Website |
http://www.proqr.com |
| Updated |
07/08/2019 |
| ProQR Therapeutics NV is a biopharmaceutical company, which engages in the discovery and development of Ribonucleic Acid RNA based therapeutics for the treatment of genetic disorders. Its initial focus is on the development of a disease-modifying therapy for the treatment of cystic fibrosis. The company was founded by Daniel de Boer, Gerard Platenburg, Henri Termeer and Dinko Valerio on February 21, 2012 and is headquartered in Leiden, the Netherlands. |
